TrialThe Lancet. Oncology2023

Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial.

Robert W Mutter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.